Dr. Danielle Sterrenberg, MD
Claim this profileIngalls Memorial Hospital
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
18 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
Stage IV
Stage III
2Cancer
Stage IV
HER2 positive
ER positive
Affiliated Hospitals
Clinical Trials Danielle Sterrenberg, MD is currently running
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. * In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). * In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. * In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: * Pembrolizumab or, * Pembrolizumab and carboplatin, or * Pembrolizumab and cisplatin * In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. * In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
More about Danielle Sterrenberg, MD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Danielle Sterrenberg, MD has experience with
- Placebo
- Pembrolizumab
- GLSI-100
- Surgery
- Active Monitoring
- Ladiratuzumab Vedotin
Breakdown of trials Danielle Sterrenberg, MD has run
Breast Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Danielle Sterrenberg, MD specialize in?
Danielle Sterrenberg, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are Stage IV.
Is Danielle Sterrenberg, MD currently recruiting for clinical trials?
Yes, Danielle Sterrenberg, MD is currently recruiting for 3 clinical trials in Harvey Illinois. If you're interested in participating, you should apply.
Are there any treatments that Danielle Sterrenberg, MD has studied deeply?
Yes, Danielle Sterrenberg, MD has studied treatments such as Placebo, Pembrolizumab, GLSI-100.
What is the best way to schedule an appointment with Danielle Sterrenberg, MD?
Apply for one of the trials that Danielle Sterrenberg, MD is conducting.
What is the office address of Danielle Sterrenberg, MD?
The office of Danielle Sterrenberg, MD is located at: Ingalls Memorial Hospital, Harvey, Illinois 60426 United States. This is the address for their practice at the Ingalls Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.